The journey of a healthcare startup is not for the faint of heart. Navigating the path to demonstrating proof of concept, finding stakeholders to champion their mission, and generating investment, takes effective communication, management, and workflow efficiency.
In a webinar scheduled for May 8th at 1pm ET, sponsored by fintech business Mercury, the discussion will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics and other life science companies. The journey of a biologic from R&D to FDA approval can take 10 years or more. Long-term success often depends on getting things right in the earliest stages. Companies have to invest in regulatory expertise at the earliest stages, building a team that balances scientific expertise with business acumen.
The webinar, moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick, will include these talking points and more:
- With NIH grant funding cutbacks, what is the opportunity for private institutions to step in?
- How to develop a strategy that assesses the use of angel investors, SBIR grants, and strategic investors
- The trends toward less government investment in research and development coupled with the rise of AI present challenges and opportunities for companies – how are they managing them?
- Mercury’s role in helping companies navigate the financial challenges of a life science startup from the financial workflows essential to any company to enabling them to clearly understand and access the HLS financial markets through its ecosystem and expertise
- How Mercury works with life science incubators and accelerators such as Mass Challenge and Cancer X
To register for this webinar, fill out the form below:
Mercury is a financial technology company, not a bank. Banking services provided by Choice Financial Group, Column N.A., and Evolve Bank & Trust, Members FDIC.
Photo: megaflopp, Getty Images